Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist.

Pradhan, Swetalina; Madke, Bhushan; Neema, Shekhar; Kabra, Poonam; Singh, Adarsh Lata; Yadav, Sangita

Pradhan, Swetalina; Madke, Bhushan; Neema, Shekhar; Kabra, Poonam; Singh, Adarsh Lata; Yadav, Sangita.

Afiliação

Pradhan S; Department of Dermatology, All India Institute of Medical Sciences, Patna, Bihar, India.
Madke B; Department of Dermatology, Venereology and Leprosy, Datta Meghe Institute of Medical Sciences, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha, Maharashtra, India.
Neema S; Department of Dermatology, Armed Forces Medical College, Pune, Maharashtra, India.
Kabra P; Department of Dermatology, Venereology and Leprosy, Datta Meghe Institute of Medical Sciences, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha, Maharashtra, India.
Singh AL; Department of Dermatology, Venereology and Leprosy, Datta Meghe Institute of Medical Sciences, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha, Maharashtra, India.
Yadav S; Department of Family Medicine, Ochsner Louisiana State University, United States of America.

Indian J Dermatol ; 66(5): 501-507, 2021.

Article em En | MEDLINE | ID: mdl-35068505